NEW YORK (Reuters Health) – REM sleep behavior disorder is associated with a ìsubstantialî risk for eventual development of neurodegenerative diseases such as Parkinson disease and Lewy body…
NEW YORK (Reuters Health) – Vilazodone, the first of a new class of antidepressants known as indolalkylamines, has been shown in a phase III trial to be effective…
NEW YORK (Reuters Health) – Elderly patients with Alzheimer’s disease treated with second-generation antipsychotics should be monitored closely for weight gain and dyslipidemia, according to an analysis of…
NEW YORK (Reuters Health) – The results of a postmortem study indicate that elderly people who commit suicide usually do not have antidepressant medications in their systems at…
NEW YORK (Reuters Health) – After the development of coronary artery disease (CAD), a subsequent diagnosis of depression is associated with an increased incidence of heart failure, even…
NEW YORK (Reuters Health) – The results of a new study suggest that tuberculosis may be cured faster by adding moxifloxacin to a standard TB treatment protocol than…
NEW YORK (Reuters Health) – Nortriptyline is more effective than paroxetine CR in reducing symptoms of depression in patients with Parkinson’s disease, according to results of a small…
Alvaro Fernandez, co-founder and CEO of Sharpbrains.com, explains the philosophy of his company, which aims to help confused doctors understand the many computerized applications that are available to…
NEW YORK (Reuters Health) – Women with depressive symptoms are at increased risk for developing coronary heart disease (CHD), especially fatal CHD, according to findings from the Nurses’…
Mark B. Lewin, MD, Chief, Cardiology, Co-Director Heart Center, Seattle Children’s Hospital and Regional Medical Center, describes the evolution of telemedicine and its uses for consultations and sending…